| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.729 | 0.004 | 0.729 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.085 0.046 CID_154699889 | ||
| 0.658 | 0.003 | 0.658 | Check point kinase 1 inhibitor | 0.08 0.038 CID_154699889 | ||
| 0.614 | 0.004 | 0.614 | EphB2 antagonist | |||
| 0.557 | 0.005 | 0.557 | Glycogen synthase kinase-3 inhibitor | |||
| 0.575 | 0.027 | 0.575 | MAP kinase 1 inhibitor | |||
| 0.525 | 0.004 | 0.525 | Xanthine oxidase inhibitor | 0.279 0.009 CID_154699889 0.182 0.024 CID_154699707 | ||
| 0.517 | 0.005 | 0.517 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.493 | 0.004 | 0.493 | Ribosomal protein S6 kinase inhibitor | |||
| 0.487 | 0.006 | 0.487 | RET inhibitor | |||
| 0.48 | 0.002 | 0.48 | Xanthine dehydrogenase inhibitor | 0.185 0.005 CID_154699889 0.092 0.018 CID_154699707 | ||
| 0.47 | 0.004 | 0.47 | Protein kinase (CK2) alpha inhibitor | |||
| 0.469 | 0.005 | 0.469 | MAP kinase 9 inhibitor | |||
| 0.463 | 0.005 | 0.463 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.464 | 0.029 | 0.464 | MAP kinase kinase 6 inhibitor | |||
| 0.461 | 0.037 | 0.461 | Angiogenesis inhibitor | |||
| 0.419 | 0.003 | 0.419 | Protein kinase C delta inhibitor | |||
| 0.407 | 0.014 | 0.407 | CDC-like kinase 4 inhibitor | |||
| 0.402 | 0.019 | 0.402 | Clk dual-specificity kinase inhibitor | |||
| 0.376 | 0.004 | 0.376 | Uric acid excretion stimulant | 0.295 0.005 CID_154699889 0.224 0.01 CID_154699707 | ||
| 0.392 | 0.028 | 0.392 | Dyrk kinase inhibitor | |||
| 0.361 | 0.003 | 0.361 | Protein kinase B beta inhibitor | |||
| 0.391 | 0.041 | 0.391 | Nootropic | |||
| 0.36 | 0.013 | 0.36 | Vascular endothelial growth factor 3 antagonist | |||
| 0.36 | 0.016 | 0.36 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.254 0.043 CID_154699889 0.23 0.056 CID_154699707 | ||
| 0.344 | 0.005 | 0.344 | Protein kinase (CK2) inhibitor | |||
| 0.342 | 0.003 | 0.342 | Protein kinase C theta inhibitor | |||
| 0.352 | 0.016 | 0.352 | TRKC antagonist | 0.18 0.079 CID_154699889 0.163 0.091 CID_154699707 | ||
| 0.344 | 0.022 | 0.344 | CDC-like kinase 2 inhibitor | |||
| 0.328 | 0.009 | 0.328 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.327 | 0.009 | 0.327 | Abl kinase inhibitor | |||
| 0.316 | 0.004 | 0.316 | Protein kinase B alpha inhibitor | |||
| 0.328 | 0.017 | 0.328 | Cyclin-dependent kinase inhibitor | |||
| 0.331 | 0.031 | 0.429 | Cyclic AMP phosphodiesterase inhibitor | 0.429 0.013 CID_154699889 0.374 0.021 CID_154699707 | CID_154699889 | |
| 0.305 | 0.008 | 0.305 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.322 | 0.031 | 0.322 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.304 | 0.015 | 0.304 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.299 | 0.012 | 0.299 | Protein kinase (CK1) delta inhibitor | |||
| 0.302 | 0.017 | 0.302 | Protein kinase (CK1) inhibitor | |||
| 0.309 | 0.032 | 0.309 | MAP kinase kinase 2 inhibitor | |||
| 0.28 | 0.004 | 0.28 | Protein kinase C alpha inhibitor | |||
| 0.317 | 0.045 | 0.317 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.281 | 0.013 | 0.281 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.277 | 0.014 | 0.277 | MAP kinase kinase 3 inhibitor | 0.193 0.144 CID_154699889 0.189 0.158 CID_154699707 | ||
| 0.267 | 0.009 | 0.267 | MAP kinase 8 inhibitor | |||
| 0.275 | 0.022 | 0.275 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.295 | 0.045 | 0.295 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.265 | 0.025 | 0.276 | Cytidine deaminase inhibitor | 0.276 0.023 CID_154699889 0.271 0.024 CID_154699707 | CID_154699889 | |
| 0.26 | 0.02 | 0.26 | Phosphodiesterase inhibitor | |||
| 0.315 | 0.078 | 0.315 | Calcium channel activator | |||
| 0.243 | 0.006 | 0.243 | MAP kinase 10 inhibitor | |||
| 0.243 | 0.008 | 0.243 | Rho-associated kinase II inhibitor | |||
| 0.279 | 0.047 | 0.279 | Tyrosine kinase inhibitor | |||
| 0.259 | 0.027 | 0.259 | Protein kinase (CK1) gamma inhibitor | |||
| 0.247 | 0.021 | 0.247 | Activin receptor-like kinase 2 inhibitor | |||
| 0.342 | 0.123 | 0.342 | 5 Hydroxytryptamine release inhibitor | 0.259 0.216 CID_154699707 | ||
| 0.231 | 0.012 | 0.231 | Platelet activating factor alpha antagonist | |||
| 0.232 | 0.018 | 0.232 | Glutamate receptor antagonist | |||
| 0.247 | 0.037 | 0.247 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.219 | 0.01 | 0.219 | Rho-associated kinase inhibitor | |||
| 0.239 | 0.03 | 0.239 | Vascular endothelial growth factor antagonist | |||
| 0.217 | 0.009 | 0.217 | MAP kinase kinase 4 inhibitor | |||
| 0.22 | 0.013 | 0.22 | Check point kinase 2 inhibitor | |||
| 0.222 | 0.017 | 0.222 | MAP kinase 12 inhibitor | |||
| 0.259 | 0.054 | 0.259 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.206 | 0.006 | 0.206 | Death-associated protein kinase 1 inhibitor | |||
| 0.251 | 0.052 | 0.251 | Death-associated protein kinase 3 inhibitor | 0.15 0.123 CID_154699889 0.165 0.102 CID_154699707 | ||
| 0.212 | 0.018 | 0.212 | MAP kinase 13 inhibitor | |||
| 0.223 | 0.03 | 0.223 | Vascular endothelial growth factor 2 antagonist | |||
| 0.198 | 0.008 | 0.198 | Protein kinase B gamma inhibitor | |||
| 0.217 | 0.027 | 0.217 | Hemostatic | 0.142 0.078 CID_154699889 0.175 0.045 CID_154699707 | ||
| 0.204 | 0.017 | 0.204 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.187 | 0.005 | 0.187 | Phosphodiesterase X inhibitor | |||
| 0.187 | 0.005 | 0.187 | Phosphodiesterase 10A inhibitor | |||
| 0.209 | 0.029 | 0.209 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.203 | 0.025 | 0.203 | Aurora-A kinase inhibitor | |||
| 0.183 | 0.006 | 0.183 | CDC7 inhibitor | |||
| 0.199 | 0.022 | 0.199 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.187 | 0.011 | 0.187 | Glutamate (mGluR) antagonist | |||
| 0.224 | 0.052 | 0.224 | LIM domain kinase 1 inhibitor | |||
| 0.237 | 0.068 | 0.237 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.335 | 0.168 | 0.335 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.227 | 0.06 | 0.227 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.201 | 0.034 | 0.201 | Death-associated protein kinase 2 inhibitor | |||
| 0.19 | 0.025 | 0.19 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.13 0.116 CID_154699889 | ||
| 0.198 | 0.036 | 0.198 | c-Src kinase inhibitor | |||
| 0.195 | 0.033 | 0.195 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.205 | 0.044 | 0.205 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.164 | 0.005 | 0.164 | MAP kinase kinase 9 inhibitor | |||
| 0.181 | 0.023 | 0.181 | Beta amyloid protein antagonist | |||
| 0.177 | 0.019 | 0.177 | Pim-1 kinase inhibitor | |||
| 0.17 | 0.013 | 0.17 | Pim-3 kinase inhibitor | |||
| 0.215 | 0.06 | 0.215 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.166 | 0.016 | 0.166 | Raf kinase inhibitor | |||
| 0.202 | 0.053 | 0.202 | Src kinase inhibitor | |||
| 0.161 | 0.012 | 0.161 | MAP-kinase-activated kinase inhibitor | |||
| 0.187 | 0.038 | 0.187 | Alkaline phosphatase inhibitor | |||
| 0.182 | 0.033 | 0.182 | MAP kinase 3 inhibitor | |||
| 0.173 | 0.026 | 0.173 | MAP kinase kinase kinase inhibitor | |||
| 0.175 | 0.03 | 0.175 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.159 | 0.017 | 0.159 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.169 | 0.028 | 0.169 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.155 | 0.018 | 0.155 | MAP kinase 14 inhibitor | |||
| 0.2 | 0.063 | 0.2 | Growth factor agonist | |||
| 0.155 | 0.019 | 0.155 | ALK inhibitor | |||
| 0.174 | 0.039 | 0.174 | MAP kinase kinase inhibitor | |||
| 0.149 | 0.014 | 0.149 | Tyk2 inhibitor | |||
| 0.174 | 0.04 | 0.174 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.136 | 0.003 | 0.136 | Bombesin agonist | |||
| 0.165 | 0.033 | 0.165 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.143 | 0.012 | 0.143 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.186 | 0.056 | 0.186 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.179 | 0.049 | 0.179 | Tyrosine-protein kinase receptor antagonist | |||
| 0.166 | 0.04 | 0.166 | Aurora-B kinase inhibitor | |||
| 0.14 | 0.017 | 0.14 | Fibroblast growth factor 3 antagonist | |||
| 0.163 | 0.043 | 0.163 | TRKA antagonist | |||
| 0.131 | 0.013 | 0.131 | MAP kinase kinase 10 inhibitor | |||
| 0.146 | 0.03 | 0.146 | Activin receptor-like kinase 4 inhibitor | |||
| 0.198 | 0.082 | 0.198 | Pyruvate kinase inhibitor | 0.188 0.088 CID_154699707 | ||
| 0.237 | 0.121 | 0.237 | Ca(v)3.3 blocker | |||
| 0.204 | 0.088 | 0.204 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.123 | 0.008 | 0.123 | AMPA receptor antagonist | |||
| 0.162 | 0.048 | 0.162 | Toll-Like receptor antagonist | |||
| 0.115 | 0.003 | 0.115 | Bombesin 3 receptor agonist | |||
| 0.138 | 0.027 | 0.138 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.125 | 0.018 | 0.125 | Raf kinase B inhibitor | |||
| 0.123 | 0.018 | 0.123 | Glutamate (mGluR) agonist | |||
| 0.126 | 0.024 | 0.126 | MAP kinase 11 inhibitor | |||
| 0.112 | 0.01 | 0.112 | mTOR inhibitor | |||
| 0.116 | 0.016 | 0.116 | I kappa B kinase 1 inhibitor | |||
| 0.116 | 0.017 | 0.116 | Phosphatidylinositol kinase inhibitor | |||
| 0.11 | 0.015 | 0.11 | Toll-Like receptor 7 antagonist | |||
| 0.109 | 0.015 | 0.109 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.134 | 0.039 | 0.134 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.116 | 0.023 | 0.139 | Adenosine A2 receptor antagonist | 0.139 0.018 CID_154699889 0.126 0.021 CID_154699707 | CID_154699889 | |
| 0.141 | 0.05 | 0.141 | Platelet activating factor antagonist | |||
| 0.163 | 0.072 | 0.163 | Polo-like kinase-3 inhibitor | |||
| 0.098 | 0.007 | 0.098 | DNA-dependent protein kinase inhibitor | |||
| 0.114 | 0.024 | 0.114 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.106 | 0.017 | 0.106 | Protein kinase C iota inhibitor | |||
| 0.109 | 0.021 | 0.109 | Fibroblast growth factor 2 antagonist | |||
| 0.118 | 0.031 | 0.118 | mTOR complex 1 inhibitor | |||
| 0.107 | 0.02 | 0.107 | Janus tyrosine kinase 1 inhibitor | |||
| 0.091 | 0.004 | 0.091 | Vascular adhesion protein 1 inhibitor | |||
| 0.154 | 0.067 | 0.154 | Growth factor antagonist | |||
| 0.122 | 0.036 | 0.122 | DNA directed RNA polymerase inhibitor | 0.108 0.047 CID_154699889 | ||
| 0.121 | 0.035 | 0.121 | Hepatocyte growth factor antagonist | |||
| 0.089 | 0.004 | 0.089 | Alpha 1d adrenoreceptor agonist | |||
| 0.097 | 0.013 | 0.097 | Protein kinase C epsilon inhibitor | |||
| 0.157 | 0.074 | 0.157 | Peroxidase inhibitor | |||
| 0.095 | 0.012 | 0.095 | Exportin-1 inhibitor | |||
| 0.095 | 0.012 | 0.095 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.108 | 0.027 | 0.108 | Phosphodiesterase 3A inhibitor | |||
| 0.175 | 0.094 | 0.175 | I kappa B kinase epsilon inhibitor | |||
| 0.136 | 0.057 | 0.136 | TRKB antagonist | |||
| 0.096 | 0.019 | 0.096 | DNA gyrase inhibitor | |||
| 0.089 | 0.013 | 0.089 | Toll-Like receptor 8 antagonist | |||
| 0.111 | 0.035 | 0.111 | Polo-like kinase-1 inhibitor | |||
| 0.099 | 0.023 | 0.256 | Adenosine A1 receptor antagonist | 0.256 0.008 CID_154699889 0.253 0.008 CID_154699707 | CID_154699889 | |
| 0.108 | 0.033 | 0.108 | Janus tyrosine kinase 2 inhibitor | |||
| 0.11 | 0.037 | 0.11 | Stem cell growth factor agonist | |||
| 0.103 | 0.03 | 0.103 | Rho-associated kinase I inhibitor | |||
| 0.198 | 0.126 | 0.464 | DNA synthesis inhibitor | 0.439 0.018 CID_154699889 0.464 0.016 CID_154699707 | CID_154699707 | |
| 0.139 | 0.068 | 0.139 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.102 | 0.032 | 0.102 | p38 MAP kinase inhibitor | |||
| 0.095 | 0.025 | 0.095 | MAP kinase kinase 8 inhibitor | |||
| 0.135 | 0.065 | 0.135 | M17 leucyl aminopeptidase inhibitor | |||
| 0.105 | 0.037 | 0.105 | Bcr-Abl kinase inhibitor | |||
| 0.072 | 0.006 | 0.072 | DNA gyrase subunit B inhibitor | |||
| 0.083 | 0.017 | 0.083 | Fatty acid synthase inhibitor | |||
| 0.133 | 0.07 | 0.133 | Sodium channel (voltage-gated) blocker | |||
| 0.109 | 0.046 | 0.109 | CDK/cyclin complex inhibitor | |||
| 0.1 | 0.038 | 0.1 | I kappa B kinase inhibitor | |||
| 0.084 | 0.024 | 0.084 | Protein kinase C beta inhibitor | |||
| 0.134 | 0.074 | 0.134 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.086 | 0.027 | 0.113 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.081 0.035 CID_154699889 0.113 0.008 CID_154699707 | CID_154699707 | |
| 0.087 | 0.029 | 0.087 | Cyclin E inhibitor | |||
| 0.068 | 0.01 | 0.068 | Glutamate (mGluR group II) agonist | |||
| 0.073 | 0.017 | 0.073 | Adenosine A2b receptor antagonist | |||
| 0.065 | 0.01 | 0.065 | Glutamate (mGluR2) agonist | |||
| 0.105 | 0.053 | 0.105 | Protein kinase C mu inhibitor | |||
| 0.081 | 0.031 | 0.114 | Adenosine A2a receptor antagonist | 0.114 0.022 CID_154699889 0.113 0.022 CID_154699707 | CID_154699889 | |
| 0.133 | 0.084 | 0.133 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.085 | 0.037 | 0.168 | Adenosine A3 receptor antagonist | 0.168 0.011 CID_154699889 0.158 0.012 CID_154699707 | CID_154699889 | |
| 0.051 | 0.007 | 0.051 | ATR kinase inhibitor | |||
| 0.081 | 0.037 | 0.081 | Glutamate (mGluR group I) antagonist | |||
| 0.071 | 0.027 | 0.071 | Heat shock protein 90 beta antagonist | |||
| 0.125 | 0.081 | 0.125 | Toll-Like receptor 9 antagonist | |||
| 0.05 | 0.007 | 0.05 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.084 | 0.042 | 0.084 | Janus tyrosine kinase 3 inhibitor | |||
| 0.099 | 0.058 | 0.099 | Fibroblast growth factor 1 antagonist | |||
| 0.061 | 0.021 | 0.061 | Glutamate (mGluR5) antagonist | |||
| 0.066 | 0.027 | 0.066 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.159 | 0.121 | 0.159 | HERG channel blocker | |||
| 0.12 | 0.082 | 0.12 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.086 | 0.048 | 0.086 | Glutamate receptor agonist | |||
| 0.062 | 0.025 | 0.062 | Transforming growth factor beta 1 antagonist | |||
| 0.13 | 0.094 | 0.13 | MAP3K9 inhibitor | |||
| 0.085 | 0.05 | 0.085 | Transforming growth factor beta 3 antagonist | |||
| 0.12 | 0.085 | 0.12 | Lck kinase inhibitor | |||
| 0.076 | 0.044 | 0.076 | Benzodiazepine agonist | |||
| 0.075 | 0.043 | 0.075 | Orexin receptor 1 antagonist | |||
| 0.135 | 0.106 | 0.135 | CF transmembrane conductance regulator agonist | |||
| 0.073 | 0.044 | 0.073 | Transforming growth factor antagonist | |||
| 0.046 | 0.018 | 0.046 | Glutamate (mGluR group II) antagonist | |||
| 0.063 | 0.035 | 0.063 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.057 | 0.03 | 0.113 | Factor IXa inhibitor | 0.094 0.011 CID_154699889 0.113 0.007 CID_154699707 | CID_154699707 | |
| 0.077 | 0.051 | 0.077 | CYP2A6 inhibitor | |||
| 0.073 | 0.047 | 0.073 | Phosphodiesterase VIII inhibitor | |||
| 0.092 | 0.066 | 0.092 | CDK2/cyclin A inhibitor | |||
| 0.057 | 0.034 | 0.057 | Pim-2 kinase inhibitor | |||
| 0.068 | 0.046 | 0.068 | Nav1.7 sodium channel blocker | |||
| 0.081 | 0.059 | 0.081 | Protein kinase A inhibitor | |||
| 0.038 | 0.017 | 0.038 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.107 | 0.086 | 0.107 | Transcription factor STAT6 inhibitor | |||
| 0.153 | 0.134 | 0.153 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.041 | 0.023 | 0.041 | CF transmembrane conductance regulator antagonist | |||
| 0.037 | 0.019 | 0.037 | Carnitine palmitoyltransferase inhibitor | |||
| 0.062 | 0.044 | 0.062 | Phosphodiesterase 1C inhibitor | |||
| 0.033 | 0.016 | 0.033 | Glutamate (mGluR2) antagonist | |||
| 0.051 | 0.034 | 0.051 | Alpha 1b adrenoreceptor agonist | |||
| 0.08 | 0.064 | 0.08 | GABA A receptor agonist | |||
| 0.088 | 0.075 | 0.088 | Vascular endothelial growth factor 1 antagonist | |||
| 0.017 | 0.005 | 0.017 | Egl nine homolog 2 inhibitor | |||
| 0.059 | 0.048 | 0.059 | I kappa B kinase 2 inhibitor | |||
| 0.052 | 0.041 | 0.052 | Myc inhibitor | |||
| 0.019 | 0.009 | 0.019 | CC chemokine 9 receptor antagonist | |||
| 0.073 | 0.064 | 0.073 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.027 | 0.019 | 0.027 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.06 | 0.052 | 0.06 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.036 | 0.029 | 0.036 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.042 | 0.035 | 0.042 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.096 | 0.09 | 0.096 | CDC-like kinase 3 inhibitor | |||
| 0.051 | 0.045 | 0.051 | Bombesin 3 receptor antagonist | |||
| 0.008 | 0.003 | 0.008 | CC chemokine 6 receptor agonist | |||
| 0.072 | 0.067 | 0.072 | Platelet growth factor antagonist | |||
| 0.062 | 0.058 | 0.062 | Syk tyrosine kinase inhibitor | |||
| 0.054 | 0.05 | 0.054 | Cyclin A inhibitor | |||
| 0.028 | 0.024 | 0.028 | MAP3K8 inhibitor | |||
| 0.033 | 0.029 | 0.033 | Orexin receptor 2 antagonist | |||
| 0.042 | 0.038 | 0.042 | Glutamate (mGluR5) agonist | |||
| 0.053 | 0.05 | 0.053 | CDK2/cyclin E inhibitor | |||
| 0.06 | 0.057 | 0.06 | Orexin receptor antagonist | |||
| 0.035 | 0.034 | 0.035 | MAP3K5 inhibitor | |||
| 0.204 | 0.203 | 0.204 | GABA C receptor rho-3 antagonist | |||
| 0.009 | 0.058 | 0.02 | Adenosine kinase inhibitor | 0.02 0.016 CID_154699889 0.02 0.016 CID_154699707 | CID_154699707 | |
| 0.112 | 0.168 | 0.136 | CC chemokine 6 receptor antagonist | 0.136 0.052 CID_154699889 0.13 0.07 CID_154699707 | CID_154699889 | |
| 0.079 | 0.145 | 0.154 | Aldehyde dehydrogenase inhibitor | 0.13 0.062 CID_154699889 0.154 0.045 CID_154699707 | CID_154699707 | |
| 0.033 | 0.103 | 0.065 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.06 0.035 CID_154699889 0.065 0.03 CID_154699707 | CID_154699707 | |
| 0.007 | 0.081 | 0.025 | Adenosine A2 receptor agonist | 0.025 0.006 CID_154699889 0.021 0.007 CID_154699707 | CID_154699889 | |
| 0.102 | 0.189 | 0.125 | Interferon gamma antagonist | 0.125 0.123 CID_154699889 | CID_154699889 | |
| 0.004 | 0.095 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.012 CID_154699889 0.014 0.012 CID_154699707 | CID_154699707 | |
| 0.053 | 0.18 | 0.129 | NADH dehydrogenase inhibitor | 0.129 0.024 CID_154699889 0.117 0.03 CID_154699707 | CID_154699889 | |
| 0.178 | 0.309 | 0.374 | Cyclophilin D inhibitor | 0.374 0.107 CID_154699889 0.34 0.13 CID_154699707 | CID_154699889 | |
| 0.078 | 0.242 | 0.149 | NOS3 expression enhancer | 0.149 0.073 CID_154699889 0.125 0.106 CID_154699707 | CID_154699889 | |
| 0.059 | 0.227 | 0.111 | Adenylate kinase inhibitor | 0.101 0.065 CID_154699889 0.111 0.053 CID_154699707 | CID_154699707 | |
| 0.015 | 0.183 | 0.079 | Adenosine deaminase inhibitor | 0.069 0.014 CID_154699889 0.079 0.009 CID_154699707 | CID_154699707 | |
| 0.034 | 0.211 | 0.071 | Glutamate dehydrogenase inhibitor | 0.071 0.055 CID_154699889 0.067 0.06 CID_154699707 | CID_154699889 | |
| 0.119 | 0.304 | 0.236 | Vasodilator, peripheral | 0.224 0.15 CID_154699889 0.236 0.138 CID_154699707 | CID_154699707 | |
| 0.017 | 0.21 | 0.102 | Phosphofructokinase-1 inhibitor | 0.093 0.034 CID_154699889 0.102 0.031 CID_154699707 | CID_154699707 | |
| 0.04 | 0.234 | 0.142 | UDP-glucose 4-epimerase inhibitor | 0.142 0.032 CID_154699889 0.13 0.037 CID_154699707 | CID_154699889 | |
| 0.018 | 0.212 | 0.056 | Biliverdin reductase inhibitor | 0.056 0.045 CID_154699707 | CID_154699707 | |
| 0.016 | 0.213 | 0.088 | Argininosuccinate synthase inhibitor | 0.088 0.022 CID_154699707 | CID_154699707 | |
| 0.006 | 0.211 | 0.024 | Adenosine A3 receptor agonist | 0.024 0.007 CID_154699889 0.024 0.006 CID_154699707 | CID_154699707 | |
| 0.171 | 0.379 | 0.474 | Antiinflammatory | 0.474 0.099 CID_154699889 0.412 0.132 CID_154699707 | CID_154699889 | |
| 0.106 | 0.34 | 0.179 | RNA-directed DNA polymerase inhibitor | 0.17 0.152 CID_154699889 0.179 0.135 CID_154699707 | CID_154699707 | |
| 0.093 | 0.342 | 0.239 | Hypoxia-inducible factor 1 alpha inhibitor | 0.239 0.111 CID_154699889 0.192 0.162 CID_154699707 | CID_154699889 | |
| 0.094 | 0.377 | 0.542 | Immunomodulator | 0.542 0.018 CID_154699889 0.537 0.018 CID_154699707 | CID_154699889 | |
| 0.099 | 0.39 | 0.137 | Heat shock protein 70 antagonist | 0.137 0.085 CID_154699707 | CID_154699707 | |
| 0.087 | 0.381 | 0.152 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.152 0.146 CID_154699889 | CID_154699889 | |
| 0.006 | 0.312 | 0.059 | Purinergic P2Y antagonist | 0.059 0.02 CID_154699889 | CID_154699889 | |
| 0.044 | 0.351 | 0.128 | Cell wall synthesis inhibitor | 0.128 0.089 CID_154699707 | CID_154699707 | |
| 0.004 | 0.314 | 0.038 | Adenosine A1 receptor agonist | 0.038 0.008 CID_154699889 0.036 0.009 CID_154699707 | CID_154699889 | |
| 0.029 | 0.348 | 0.136 | AMP-activated protein kinase stimulant | 0.111 0.058 CID_154699889 0.136 0.037 CID_154699707 | CID_154699707 | |
| 0.018 | 0.342 | 0.052 | Heparanase inhibitor | 0.052 0.039 CID_154699707 | CID_154699707 | |
| 0.049 | 0.409 | 0.199 | Vasodilator | 0.199 0.106 CID_154699889 0.182 0.12 CID_154699707 | CID_154699889 | |
| 0.053 | 0.424 | 0.127 | DNA repair enzyme inhibitor | 0.127 0.059 CID_154699889 0.118 0.077 CID_154699707 | CID_154699889 | |
| 0.07 | 0.48 | 0.387 | Antibacterial | 0.331 0.113 CID_154699889 0.387 0.083 CID_154699707 | CID_154699707 | |
| 0.071 | 0.493 | 0.275 | Vasodilator, coronary | 0.257 0.128 CID_154699889 0.275 0.11 CID_154699707 | CID_154699707 | |
| 0.005 | 0.441 | 0.015 | Adenosine A2b receptor agonist | 0.015 0.009 CID_154699889 0.015 0.009 CID_154699707 | CID_154699707 | |
| 0.021 | 0.478 | 0.205 | Thrombolytic | 0.144 0.086 CID_154699889 0.205 0.05 CID_154699707 | CID_154699707 | |
| 0.043 | 0.527 | 0.187 | Transcription factor NF kappa B inhibitor | 0.187 0.182 CID_154699707 | CID_154699707 | |
| 0.066 | 0.569 | 0.217 | Caspase 3 stimulant | 0.213 0.151 CID_154699889 0.217 0.146 CID_154699707 | CID_154699707 | |
| 0.013 | 0.63 | 0.151 | Anticoagulant | 0.151 0.079 CID_154699707 | CID_154699707 | |
| 0.019 | 0.654 | 0.203 | Insulin secretagoues | 0.192 0.04 CID_154699889 0.203 0.034 CID_154699707 | CID_154699707 | |
| 0.018 | 0.66 | 0.173 | DNA methylase inhibitor | 0.149 0.118 CID_154699889 0.173 0.098 CID_154699707 | CID_154699707 | |
| 0.02 | 0.703 | 0.21 | Antithrombotic | 0.21 0.166 CID_154699707 | CID_154699707 | |
| 0.01 | 0.709 | 0.159 | Free radical scavenger | 0.159 0.135 CID_154699707 | CID_154699707 | |
| 0.01 | 0.714 | 0.327 | Immunostimulant | 0.246 0.098 CID_154699889 0.327 0.071 CID_154699707 | CID_154699707 | |
| 0.001 | 0.736 | 0.011 | Purinergic P2Y agonist | 0.011 0.01 CID_154699707 | CID_154699707 | |
| 0.001 | 0.747 | 0.015 | Purinergic receptor agonist | 0.014 0.011 CID_154699889 0.015 0.011 CID_154699707 | CID_154699707 | |
| 0.001 | 0.747 | 0.015 | Purinergic P2 agonist | 0.014 0.011 CID_154699889 0.015 0.011 CID_154699707 | CID_154699707 | |
| 0.002 | 0.758 | 0.027 | Purinergic P2X agonist | 0.026 0.02 CID_154699889 0.027 0.019 CID_154699707 | CID_154699707 | |
| 0.005 | 0.766 | 0.171 | Topoisomerase I inhibitor | 0.151 0.041 CID_154699889 0.171 0.034 CID_154699707 | CID_154699707 | |
| 0.003 | 0.776 | 0.017 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.017 0.008 CID_154699889 0.017 0.008 CID_154699707 | CID_154699707 | |
| 0.005 | 0.822 | 0.131 | Aminoacyl-tRNA synthetase inhibitor | 0.12 0.03 CID_154699889 0.131 0.025 CID_154699707 | CID_154699707 | |
| 0.013 | 0.857 | 0.27 | Apoptosis agonist | 0.266 0.199 CID_154699889 0.27 0.195 CID_154699707 | CID_154699707 | |
| 0.005 | 0.896 | 0.161 | Antioxidant | 0.161 0.152 CID_154699707 | CID_154699707 | |
| 0.003 | 0.935 | 0.076 | Selectin antagonist | 0.059 0.05 CID_154699889 0.076 0.039 CID_154699707 | CID_154699707 | |
| 0.007 | 0.944 | 0.273 | Immunosuppressant | 0.256 0.143 CID_154699889 0.273 0.132 CID_154699707 | CID_154699707 | |
| 0.004 | 0.949 | 0.249 | Platelet antagonist | 0.249 0.073 CID_154699707 | CID_154699707 | |
| 0.01 | 0.955 | 0.186 | Hepatoprotectant | 0.175 0.084 CID_154699889 0.186 0.074 CID_154699707 | CID_154699707 | |
| 0.006 | 0.955 | 0.24 | Platelet adhesion inhibitor | 0.163 0.094 CID_154699889 0.24 0.053 CID_154699707 | CID_154699707 | |
| 0.032 | 0.99 | 0.33 | Peptidyltransferase inhibitor | 0.31 0.021 CID_154699889 0.33 0.016 CID_154699707 | CID_154699707 | |
| 0.005 | 0.974 | 0.258 | Hypoglycemic | 0.222 0.094 CID_154699889 0.258 0.072 CID_154699707 | CID_154699707 | |
| 0.008 | 0.985 | 0.175 | DNA polymerase I inhibitor | 0.144 0.053 CID_154699889 0.175 0.037 CID_154699707 | CID_154699707 | |
| 0.015 | 0.996 | 0.251 | Interleukin 2 agonist | 0.251 0.117 CID_154699707 | CID_154699707 | |
| 0.004 | 0.995 | 0.3 | Angiogenesis stimulant | 0.238 0.075 CID_154699889 0.3 0.049 CID_154699707 | CID_154699707 | |
| 0.002 | 0.995 | 0.047 | Protein 50S ribosomal subunit inhibitor | 0.047 0.043 CID_154699707 | CID_154699707 | |
| 0.001 | 0.996 | 0.034 | Antibiotic Aminoglycoside-like | 0.034 0.029 CID_154699707 | CID_154699707 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |